The recovery of a kidney transplant recipient from COVID-19 has provided insight into the treatment of immunosuppressed coronavirus patients.
Implications of COVID-19 for inflammatory bowel disease patients with comments from Professor of Gastroenterology Dr. Giovanni Monteleone.
Targeted Multiple Myeloma Treatment Melflufen Shows Efficacy for Difficult-to-Treat Triple-Class Refractory Disease
The targeted peptide-drug conjugate melflufen has shown efficacy for the treatment of triple-class refractory multiple myeloma.
Inovio Receives $5 Million Grant from Bill and Melinda Gates Foundation for COVID-19 Vaccine Program
Inovio Pharmaceuticals (Nasdaq: INO) has announced its recipientship of a $5 million grant from the Gates Foundation for their COVID-19 vaccine program.
Clinical Trial Demonstrates Enhancement of Immune Response to HIV by Gilead’s TLR7 Agonist Vesatolimod
Gilead (Nasdaq: GILD) has announced clinical trial results demonstrating the enhancement of the immune response to HIV by the TLR7 agonist Vesatolimod.
NuVasive, Inc. (Nasdaq: NUVA) has announced a recent publication demonstrating the efficacy of their synthetic bioactive putty in lumbar fusion.
Biocept, Inc. (Nasdaq: BIOC) has announced a clinical research publication further validating its cancer-detecting liquid biopsy platform.
Moderna, Inc. (Nasdaq: MRNA) has announced the completion of enrollment for a Phase 2 study evaluating its cytomegalovirus vaccine.
Gilead Sciences, Inc. (Nasdaq: GILD), has initiated two phase 3 clinical trials of the anti-viral agent remdesivir for the treatment of COVID-19.